These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
498 related items for PubMed ID: 18227814
21. Hypertrophic cardiomyopathy in the elderly. Kubo T, Kitaoka H, Okawa M, Nishinaga M, Doi YL. Geriatr Gerontol Int; 2010 Jan; 10(1):9-16. PubMed ID: 20102377 [Abstract] [Full Text] [Related]
22. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. Alcalai R, Seidman JG, Seidman CE. J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152 [Abstract] [Full Text] [Related]
23. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy. Smolik S, Domal-Kwiatkowska D, Kapral M, Weglarz L. Acta Pol Pharm; 2010 Jan; 67(6):669-72. PubMed ID: 21229884 [Abstract] [Full Text] [Related]
24. A contemporary approach to hypertrophic cardiomyopathy. Ho CY, Seidman CE. Circulation; 2006 Jun 20; 113(24):e858-62. PubMed ID: 16785342 [No Abstract] [Full Text] [Related]
25. Genetic basis of hypertrophic cardiomyopathy. Lind JM, Chiu C, Semsarian C. Expert Rev Cardiovasc Ther; 2006 Nov 20; 4(6):927-34. PubMed ID: 17173506 [Abstract] [Full Text] [Related]
26. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Kabaeva ZT, Perrot A, Wolter B, Dietz R, Cardim N, Correia JM, Schulte HD, Aldashev AA, Mirrakhimov MM, Osterziel KJ. Eur J Hum Genet; 2002 Nov 20; 10(11):741-8. PubMed ID: 12404107 [Abstract] [Full Text] [Related]
27. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy]. Domal-Kwiatkowska D, Smolik S, Mazurek U, Moric E, Polońska J, Nowalany-Kozielska E, Glanowska G, Wodniecki J, Szarek J, Wilczewski P, Kozakiewicz K, Tendera M, Wilczok T. Wiad Lek; 2000 Nov 20; 53(1-2):4-21. PubMed ID: 10806915 [Abstract] [Full Text] [Related]
28. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Cardim N, Perrot A, Santos S, Morgado P, Pádua M, Ferreira S, Reis RP, Monteiro C, Ferreira T, Correia JM, Osterziel KJ. Rev Port Cardiol; 2005 Dec 20; 24(12):1463-76. PubMed ID: 16566405 [Abstract] [Full Text] [Related]
29. The development of familial hypertrophic cardiomyopathy: from mutation to bedside. Brouwer WP, van Dijk SJ, Stienen GJ, van Rossum AC, van der Velden J, Germans T. Eur J Clin Invest; 2011 May 20; 41(5):568-78. PubMed ID: 21158848 [Abstract] [Full Text] [Related]
30. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Kaski JP, Syrris P, Burch M, Tomé-Esteban MT, Fenton M, Christiansen M, Andersen PS, Sebire N, Ashworth M, Deanfield JE, McKenna WJ, Elliott PM. Heart; 2008 Nov 20; 94(11):1478-84. PubMed ID: 18467357 [Abstract] [Full Text] [Related]
31. Familial hypertrophic cardiomiopathy: molecular basis and genotype-phenotype correlations. Cuda G, Lamberti A, Perrotti N, Perticone F, Mattioli PL. Rev Port Cardiol; 1998 Oct 20; 17 Suppl 2():II21-31. PubMed ID: 9835779 [Abstract] [Full Text] [Related]
32. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F. J Cardiovasc Med (Hagerstown); 2006 Aug 20; 7(8):601-7. PubMed ID: 16858239 [Abstract] [Full Text] [Related]
33. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy? Brito D, Madeira H. Rev Port Cardiol; 2005 Sep 20; 24(9):1137-46. PubMed ID: 16335287 [Abstract] [Full Text] [Related]
34. [Sudden death at young age and the importance of molecular-pathologic investigation]. Wilde AA, van Langen IM, Mannens MM, Waalewijn RA, Maes A. Ned Tijdschr Geneeskd; 2005 Jul 16; 149(29):1601-4. PubMed ID: 16078763 [Abstract] [Full Text] [Related]
35. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. Bos JM, Towbin JA, Ackerman MJ. J Am Coll Cardiol; 2009 Jul 14; 54(3):201-11. PubMed ID: 19589432 [Abstract] [Full Text] [Related]
36. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey. Charron P, Villard E, Sébillon P, Laforêt P, Maisonobe T, Duboscq-Bidot L, Romero N, Drouin-Garraud V, Frébourg T, Richard P, Eymard B, Komajda M. Heart; 2004 Aug 14; 90(8):842-6. PubMed ID: 15253947 [Abstract] [Full Text] [Related]
37. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects. Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Kaneda T, Inoue M, Masuda E, Mabuchi H. J Intern Med; 2005 Sep 14; 258(3):216-24. PubMed ID: 16115294 [Abstract] [Full Text] [Related]
39. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy. Yang JH, Zheng DD, Dong NZ, Yang XJ, Song JP, Jiang TB, Cheng XJ, Li HX, Zhou BY, Zhao CM, Jiang WP. Chin Med J (Engl); 2006 Nov 05; 119(21):1785-9. PubMed ID: 17097032 [Abstract] [Full Text] [Related]
40. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Circulation; 2008 Oct 07; 118(15):1541-9. PubMed ID: 18809796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]